1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Teligent Inc - Company Capsule

Teligent Inc - Company Capsule

  • September 2016
  • -
  • Canadean Ltd
  • -
  • 26 pages

Summary
This report is a crucial resource for industry executives and anyone looking to access key information about "Teligent Inc"

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Key Findings
- Identifies crucial company information about "Teligent Inc" along with major products and services for business intelligence requirements.

- Provides key ratios on company's financial performance.

- Identifies key employees to assist with key business decisions.

- Provides annual and interim financial ratios.

Synopsis
Canadean's "Teligent Inc - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, recent developments, key employees as well as company locations and subsidiaries.

Reasons To Buy
- Enhance your understanding of "Teligent Inc"

- Increase business/sales activities by understanding customers' businesses better.

- Recognize potential partnerships and suppliers.

- Qualify prospective partners, affiliates or suppliers.

- Acquire up-to-date company information and an understanding of the company's financial health.

Key Highlights
Teligent Inc (Teligent), formerly IGI Laboratories, Inc. is a manufacturer and supplier of pharmaceutical products. The company offers topical prescription drugs and sterile injectable products. Its products include econazole cream, fluocinolone acetonide ointment, fluocinolone acetonide cream, fluocinolone acetonide topical solution and lidocaine. Teligent markets its products under the brands of Cefotan, Zinacef, Fortaz and Zantac.. The company offers development, formulation and manufacturing services. It serves pharmaceutical, cosmetic and drug manufacturing industries. Teligent has facilities located in New Jersey, the US; Toronto, Canada; and Tallinn, Estonia. The company sells its products through a network of pharmacies located across the US. Teligent is headquartered in Buena, New Jersey, the US.

Table Of Contents

Teligent Inc - Company Capsule
Table of Contents
1 Teligent Inc
2 Teligent Inc - Key Employees
3 Teligent Inc - Major Products and Services
4 Teligent Inc - Key Events
5 Teligent Inc - Locations and Subsidiaries
5.1 Teligent Inc - Head Office
5.2 Teligent Inc - Other Locations and Subsidiaries
6 Teligent Inc - Business Analysis
6.1 Teligent Inc - Company Overview
7 Teligent Inc - Company Financial Analysis
7.1 Teligent Inc - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
8 Teligent Inc - Interim ratios
8.1.1 Teligent Inc - Financial ratios: Capital Market Ratios
8.2 Teligent Inc - Financial Performance and Ratio Charts
8.2.1 Teligent Inc - Revenue and Operating margin
8.2.2 Teligent Inc - Asset and Liabilities
8.2.3 Teligent Inc - Operational Efficiency
8.2.4 Teligent Inc - Solvency
8.3 Teligent Inc - Key Competitors
9 Teligent Inc - Recent Developments
10 Appendix
10.1 Methodology
10.2 Teligent Inc - Ratio Definitions
10.3 Disclaimer

List of Tables
Table 1: Teligent Inc - Key Employees
Table 2: Teligent Inc - Major Products and Services
Table 3: Teligent Inc - Key Events
Table 4: Teligent Inc - Subsidiaries
Table 5: Teligent Inc - Annual ratios
Table 6: Teligent Inc - Interim ratios
Table 7: Teligent Inc - Capital Market Ratios

List of Figures
Figure 1: Teligent Inc - Revenue and Operating Profit
Figure 2: Teligent Inc - Asset and Liabilities
Figure 3: Teligent Inc - Operational Efficiency
Figure 4: Teligent Inc - Solvency

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.